Recent judgments from the Court of Justice of the European Union underscore the heightened scrutiny of agreements involving value transfers between pharmaceutical companies under EU competition law. Partner Ingrid Vandenborre, counsel Michael Frese and associates Antonio Cammalleri and Leonor Catela discuss the implications for future patent settlements and market practices.
Patent Settlements Under EU Competition Law: The EU Court of Justice Takes a Touch Stance Against Value Transfers From Originators to Generics
Utilities Law Review